ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$ZBIO:NASDAQ · Zenas Biopharma Inc - US

Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies.

More about this company

Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.

Sector: health

Conviction from: NASDAQ

52-week range: 13.5044.60

2 tracked filer(s) hold this · 1 opened, 1 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 68. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy16,907$455,9820.0%
Steve Cohen / Point7275Added +512%98,787$2,664,2850.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

FiledFormActivist% of classConviction
2026-05-05SCHEDULE 13DMOULDER LEON O JR5.1%Medfiling
2026-04-02SCHEDULE 13D/AMOULDER LEON O JR4.8%Lowfiling
2026-01-14SCHEDULE 13DMOULDER LEON O JR5.2%Medfiling

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-05-18MOULDER LEON O JR (cluster of 2)director+officer60,000$1,012,800Form 4
2026-04-29MOULDER LEON O JR (cluster of 2)director+officer60,000$1,067,200Form 4
2026-04-01Fairmount Funds Management LLC (cluster of 2)director150,000$3,000,000Form 4
2026-03-31MOULDER LEON O JR (cluster of 3)director+officer54,000$1,021,140Form 4
2026-03-31Lu Hongbo (cluster of 3)director75,000$1,500,000Form 4
2026-02-13Lu Hongbo (cluster of 3)director25,985$584,662Form 4
2026-02-13Allen Patricia L (cluster of 3)director19,860$499,746Form 4
2026-02-03MOULDER LEON O JR (cluster of 3)director+officer57,000$1,023,720Form 4
2026-01-09MOULDER LEON O JR (cluster of 3)director+officer100,000$1,639,000Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.